NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,171 | -11.4% | 109,423 | -13.6% | 2.62% | -5.0% |
Q2 2023 | $12,610 | +10.3% | 126,607 | +2.0% | 2.75% | +12.4% |
Q1 2023 | $11,433 | +0.9% | 124,140 | +0.2% | 2.45% | -3.5% |
Q4 2022 | $11,336 | -99.9% | 123,871 | +0.3% | 2.54% | +2.6% |
Q3 2022 | $9,421,000 | -10.0% | 123,542 | -0.3% | 2.47% | -0.3% |
Q2 2022 | $10,473,000 | -1.9% | 123,872 | +2.1% | 2.48% | +18.5% |
Q1 2022 | $10,676,000 | +19.5% | 121,295 | +19.7% | 2.09% | +4.0% |
Q4 2021 | $8,936,000 | +19.0% | 101,362 | +12.0% | 2.01% | +2.7% |
Q3 2021 | $7,507,000 | -4.4% | 90,532 | +5.2% | 1.96% | +2.5% |
Q2 2021 | $7,851,000 | +10.5% | 86,046 | +3.5% | 1.91% | +4.9% |
Q1 2021 | $7,106,000 | -10.8% | 83,134 | -1.4% | 1.82% | -5.5% |
Q4 2020 | $7,962,000 | +10.6% | 84,345 | +1.9% | 1.93% | +5.9% |
Q3 2020 | $7,201,000 | -99.9% | 82,809 | +0.1% | 1.82% | -7.2% |
Q2 2020 | $7,046,974,000 | +97517.0% | 82,707 | -0.8% | 1.97% | -17.8% |
Q1 2020 | $7,219,000 | -40.2% | 83,371 | -34.7% | 2.39% | -45.2% |
Q4 2019 | $12,079,000 | – | 127,597 | – | 4.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
Elefante Mark B | 5,619 | $417,000 | 3.78% |
SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |